Canyon Capital Advisors’s Encompass Health EHC Stock Holding History

Canyon Capital Advisors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Hold	0	–	-$98K	–	60
2013 Q4	–	Hold	0	–	–	–	46

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Canyon Capital Advisors's EHC Position: Q3 2022 in Review

Canyon Capital Advisors sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 433,820 shares — an estimated $19.3M sold.

Canyon Capital Advisors first reported a position in EHC in Q3 2021 and held it in 4 quarters. The position peaked at $82.6M in Q1 2022. 347 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

Canyon Capital Advisors reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
Canyon Capital Advisors sold 433,820 Encompass Health shares in Q3 2022, an estimated $19.3M.
Canyon Capital Advisors first reported a position in Encompass Health in Q3 2021 and held it in 4 quarters.
Canyon Capital Advisors's Encompass Health position peaked at $82.6M in Q1 2022.
347 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on Canyon Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.